The 21st Century Cures Act will lower FDA drug licensing standards by allowing pharma to avoid conducting large randomized clinical trials on pharmaceutical products under development.

The non-profit National Vaccine Information Center (NVIC) says the proposed 21st Century Cures Act (H.R. 6) will endanger the public health by lowering scientific and informed consent standards used by the Food and Drug Administration (FDA) to license experimental biological products (vaccines), drugs and medical devices in order to expedite delivery to the U.S. market. Under the proposed law, drug companies could avoid conducting large randomized clinical trials and researchers would be able to test new products on humans without obtaining informed consent.

Read more here: The 21st Century Cures Act will lower FDA drug licensing standards by allowing pharma to avoid conducting large randomized clinical trials on pharmaceutical products under development.

Please follow and like us:

Related Post

Leave a Reply